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ABSTRACT 
Objective: Dyslipidaemia is considered a high-risk factor for inducing atherosclerosis and cardiovascular diseases (CVDs). This study aims to 
investigate the anti-hyperlipidemic effect of the co-administration of the ethanol extracts of both ginger (root and rhizome) and leek (leaves and 
bulbs) in addition to the aqueous extract of gum arabic.  
Methods: Rats were divided into eight groups: Hyperlipidaemia was induced in rats by a single intraperitoneal injection of Poloxamer 407 (P-407) 
[1 g/kg], negative control [saline injected], hyperlipidemic control [P-407 injected], positive control [Atorvastatin 70 mg/kg], groups four, five and 
six received ginger extract (400 mg/kg), leek extract (500 mg/kg) and gum arabic aqueous extract (7.5 g/kg) respectively and groups seven and 
eight received a co-administration of ginger, leek and gum arabic extracts at doses A and B respectively. Lipid profile was monitored. The profiling 
of all the tested extracts was performed by LC-ESI/MS and HPLC.  
Results: A significant anti-hyperlipidemic activity (P<0.05) was seen for group eight among all the tested groups producing ≈54%, 72%, 50% and 
72% decrease in the measured parameters total cholesterol (TC), triglycerides (TG), low-density lipoprotein (LDL) and very-low-density lipoprotein 
(VLDL) respectively. An overall of 56 and 45 compounds were tentatively identified in the ethanol extracts of ginger and leek, respectively. 
Galactose and arabinose sugars were found to be the major saccharides in gum arabic and glucuronic acid was the major polyuronide part. 
Conclusion: the co-administration of a group of natural extracts in the given concentration proved to be more effective than the use of synthetic 
drugs or the use of a single component.  
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INTRODUCTION  
Dyslipidaemia can be defined as the elevation of cholesterol, 
triglycerides, and low-density lipoprotein cholesterol (LDL-C) serum 
levels while maintaining low serum levels of high-density lipoprotein 
cholesterol (HDL-C). This imbalance is considered a high-risk factor 
for inducing atherosclerosis and CVDs, which are considered the most 
common cause of death in both western and eastern countries [1]. As 
per the recommendation of the National Cholesterol Education 
Program, individuals with blood cholesterol levels above 240 mg/dl 
are considered hyper-cholesterolemic [2]. Many people achieve 
healthy levels by eating a balanced diet and through other aspects of 
their lifestyle including quitting smoking, exercise. However, some 
require medication to prevent additional health problems. 
Traditionally, natural remedies were used to overcome such an 
imbalance in lipids metabolism and are claimed to be useful in 
controlling hyperlipidaemia and associated pathologies [3]. According 
to Hasani-Ranjbar et al. [4], About 53 clinical trials were performed to 
review the efficacy of several natural sources in the management of 
hyperlipidaemia, twenty-two plants of which were proven to show a 
significant decrease in total cholesterol and LDL cholesterol. Plants 
such as Ginger [Zingiber officinale R.], family Zingiberaceae, 
Leek, Allium ampeloprasum var. porrum (L.) also known as A. porrum, 
family Alliaceae (Liliaceae), and the edible dried gummy exudate gum 
arabic are all known to possess anti-hyperlipidemic activities in 
addition to other diverse biological effects which have been reported 
for this three species, such as anti-inflammatory, antitumor, 
antioxidant, hypotensive, prebiotic and ant-diabetic activities [5-10]. 
Synergy is a process in which the combined effect of some substances 
cooperates to reach a greater effect than the sum of their separate 
effects. Previous trials for the use of combined herbal therapy was 
reported for cancer treatment [11], hyperlipidemia [12] also a 
combination of herbal and synthetic drugs was under investigation for 
the treatment of diabetes [13, 14] as a mean to enhance therapeutic 
effects, reduce side effects and overcome drug resistance. 
In the present work, an evaluation of the anti-hyperlipidemic effect of 
the co-administration of the ethanol extracts of both ginger (root and 
rhizome) and leek (leaves and bulb) and the aqueous solution of gum 
arabic versus Atorvastatin in a P-407 induced hyperlipidemia model in 
rats was performed. Examination of the active constituents of the tested 
extracts was done using liquid chromatography-electrospray ionization-
mass spectroscopy/mass-mass spectroscopy (LC-ESI-MS/MS2) analysis 
and quantitative high-performance liquid chromatography (HPLC) 
analysis of the aqueous solution of gum arabic.  
MATERIALS AND METHODS  
Chemicals and reagents 
Ator® (Atorvastatin) 40 mg tablets (EIPICO Company [Egyptian 
international pharmaceutical industries company–Egypt). Tablets were 
crushed into powder, dissolved in distilled water (120 mg/25 ml). 
Poloxamer 407, [Sigma-Aldrich Chemical Co. The USA]. P-407 was 
prepared by dissolving 8 g/100 ml saline for injection and then 
refrigerated overnight to facilitate its dissolution [15]. 70% ethanol (El 
Gomhoria Company). 
Plant materials 
Both dried entire ginger root and rhizome [Zingiber officinale R.] and 
Gum Arabic (Acacia senegal) were purchased from local Harazz 
commercial stores of Medicinal Plants, Cairo-Egypt. Leek (Allium 
porrum) plant leaves and bulbs were collected from Nahia region, 
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Giza city, Egypt during May and June 2015. All used plants were 
botanically identified and authenticated by Dr. Abdul Halim Abdul 
Majali Mohammed, Head of Flora Research and Plant Classification 
department, Agricultural Research Centre. Three voucher specimens 
(Zof-152/2017 for ginger, Apo-153/2017 for leek and Gar-154/2017 
for gum) were deposited in the herbarium of Pharmacognosy 
department, Faculty of Pharmacy, Helwan University.  
Extracts preparation 
One Kg of dried ginger (root and rhizome) and one Kg of leaves and 
bulbs of leek were air-dried and ground to powder using a clean mill 
and mortar. They were separately macerated in (2LX3) 70% ethanol 
and left to stand 72 h with shaking until complete extraction. After 
filtration, the alcoholic extracts were concentrated under reduced 
pressure at 45 °C. The yields of the alcoholic extracts were 12.7%, 
28.8% for ginger and leek, respectively. Aqueous solution of gum 
arabic was freshly prepared by dissolving 15 g of gum arabic in 50 
ml distilled water to obtain 30% solution. 
LC/MS analysis 
LC/MS analysis was performed on triple stage quadruple mass 
spectrometer, TSQ Quantum Access MAX, Thermo Scientific, New 
York, USA, equipped with electrospray ionization (ESI) operated in 
the positive ionization mode (60 ev). Identification of the content of 
the extract was carried on the Accela U-HPLC system, which was 
composed of Accela 1250 quaternary pump and Accela open 
autosampler, New York, USA (operated at 25 oC). Hypersil Gold 
column (C18 bonded ultrapure silica-based column) 50 mm × 2.0 
mm (1.9 μm), Thermo-scientific, New York, USA. Isocratic elution 
using fresh prepared Acetonitrile (A): 0.2% formic acid aqueous 
solution (B) (90:10) at room temperature. Flow rate (250 μl/min). 
X-calibur software version 2.2 was used to control all parameters of 
UPLC and MS and analysis of the obtained data. 
Sugar analysis after hydrolysis of gum arabic by HPLC 
Galactose: arabinose: rhamnose ratios in gum arabic extract was 
determined using HPLC. Aliquots of 0.03-0.05 g of the gum were 
weighed out accurately into tarred 15 cm3 stoppered Pyrex test tubes 
and 10 cm3 of 4% w/w sulphuric acid added to each. The tubes were 
placed in a water bath at 100 °C for 4 h and were then reweighed and 
made up to the original weight by the addition of distilled water. The 
solutions were neutralized by adding 2 g BaCO3 and shaking overnight. 
The filtered (0.45 urn) hydrolysates were analysed using the Perkin-
Elmer Series 10 HPLC system equipped with a 25 x 0.46 cm SS Amino 
column (phase separations). The sample (60 µdm) was injected onto the 
column using 80:20 acetonitrile: water eluent at 22 °C and at a flow rate 
of 0.8 cm3/min. The retention times of the monosaccharide components 
were monitored using a Millipore Waters differential refractometer 
R401 and the proportions of each were determined by integration of the 
peaks. All analytes were compared with injected standards separately 
and calculated according to the following equation:  
Animals 
Forty Sprague-Dawley Albino adult male rats weighing 130-180 g, 
purchased from the animal house of National Research Centre, were 
used. The animals were housed in standard metal cages in an air-
conditioned room at 22±3 °C, 55±5% humidity for 12 h [light and dark 
cycles were maintained]. The animals were left for an initial adaptation 
period of 7 d and were supplied with a standard pellet diet and water ad 
libitum. The experiment was carried for 4 d. All animal procedures were 
performed in accordance with the recommendation of the national 
institute of health guide for care and use of laboratory animals NIH 
guide, publication No 85-23: (revised1985) US department of health, 
education and welfare, specific national laws were applied and all 
experiments were examined by the appropriate ethics committees, 
approval No: 2017/FPHU150.  
Experimental design and induction of hyperlipidemia 
Rats were randomly divided into 8 groups, each comprising 8 rats. 
All rats were subjected to a six hours fasting. Animals of the first 
group were kept as negative control injected intraperitoneal [i. p.] 
with saline. Rats of the remaining seven groups were given 1g/kgbw 
(bodyweight) of Poloxamer-407 to induce hyperlipidaemia in a 
single dose on day one [14]. Group 2 was kept as hyperlipidemic 
control. Two hours later, group three were given atorvastatin (70 
mg/kgbw) [16] and was considered as positive control. Similarly, 
group 4, 5 and 6 were administered 400 mg/kgbw of the ethanol 
extract of ginger [17], 500 mg/kgbw of the ethanol extract of leek 
[18] and 7.5 g/kgbw of the aqueous solution of gum arabic [19] 
respectively. As for group 7, it was co-administered dose A of the 
tested extracts, (ethanol extract of ginger (200 mg/kgbw), leek (250 
mg/kgbw) and 30% aqueous solution of gum arabic 3.75 g/kgbw). 
While group eight was co-administered dose B (ethanol extract of 
ginger 400 mg/kgbw, leek 500 mg/kgbw and 30% aqueous solution 
of gum Arabic 7.5 g/kgbw). This was repeated once daily for 3 
consecutive days by oral gavage [16]. 
Collection of blood samples 
At the end of the experimental period (4 d) and after 12 h of fasting, the 
rats were anesthetized with isoflurane and oxygen then sacrificed. Blood 
was collected from the hepatic portal vein in centrifuge tubes and were 
incubated at room temperature for 30 min. Serum was obtained by 
centrifugation of blood samples [4000 rpm/15 min]. All samples were 
stored at-20 °C until further analysis. Handling procedures were 
conducted in accordance with the Institutional Ethics Committee and in 
accordance with the recommendations for the proper care and use of 
laboratory animals (NIH publication no. 85-23, revised 1985). 
Biochemical analysis 
Serum total cholesterol and triglycerides were estimated by enzymatic 
methods of CHOD-PAP and GPO-Trinder method [20]. Estimation of 
(HDL-C) was done by precipitation method [17]. All parameters were 
analysed by Spectrophotometric with quantitative diagnostic 
commercial kits. Serum concentrations of very low-density lipoprotein-
cholesterol (VLDL-C) and Low-density lipoprotein-Cholesterol (LDL-C) 
were calculated using Friedewald's formula [21]. 
Statistical analysis 
Data were expressed as means±standard error of means [SEM]. 
Assessment of the results was performed using a one-way analysis of 
variance [ANOVA] followed by Dunnett as post hoc test using SPSS 
program, version 16. The level of significance was set at P<0.05.  
RESULTS AND DISCUSSION 
Anti-hyperlipidemic effect 
The concept of the use of a herbal combination to treat several 
diseases was the subject of many studies throughout the years [21-
23], in the majority of which the combined administration of crude 
plants or their extracts proved to be beneficial in their intended action 
having the added value of being of natural sources and minimal side 
effects when compared to synthetic medications. Results illustrated in 
(table 1) and (fig. 1) showed that administration of P-407 induced 
significant elevation (P<0.05) in serum levels of TC by ≈ 4 folds, TG by 
≈ 8 folds, HDL-C by ≈ 1.7 fold, LDL-C levels by ≈ 6 folds and VLDL-C 
levels by ≈ 8 folds as compared to a negative control group. The results 
also proved that group 8 showed a more effective anti-hyperlipidemic 
effect than group 7 and all the individually administered extracts. 
Administration of dose B of the tested combination (group 8) showed 
a significant (P<0.05) decrease in TG and LDL-C when compared to 
both a positive control and the anti-hyperlipidemic control group. It 
led to a more effective decrease in the lipid profile in all the measured 
parameters ranging from 10 to 15% more than that caused by 
atorvastatin reference. In addition to a significant difference seen in 
the TC and LDL level compared to the hyperlipidemic model. Although 
the administration of each component individually showed a 
promising anti-hyperlipidemic effect especially in case of TG and 
VLDL, the co-administered doses in group 8 surpassed the effect of 
each component delivered individually causing 54%, 72.5%, 51.2% 
and 72.5% reduction in TC, TG, LDL-C and VLDL-C levels respectively 
when compared to a positive control group. Moreover, TG, VLDL-C 
levels of this group were significantly decreased by 25.9 % and 25.9 %, 
respectively surpassing the effect of atorvastatin used as a positive 
standard drug. This may be explained by a synergistic effect of all the 
included components acting by a multi mechanism of action, including 
decreased intestinal fat absorption and/or decreased lipid 
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biosynthesis and/or enhanced cholesterol elimination of ginger [17, 
24]. In addition to the effect of sulphur amino acid compounds known 
to lower all the measured markers in the lipid profile [25]. The 
viscosity of the fermentable dietary fibers in gum arabic also 
contributes by producing an acidic PH during its fermentation process 
in the intestine to promote lipid excretion in stool [26]. Based on these 
results, such combination can be used alone as prophylactic 
management to hyperlipidemia as phytopharmaceutical, or as a 
booster to known anti-hyperlipidemic drugs, Where treating 
dyslipidaemia requires lifelong use of anti-hyperlipidemic drugs. 
  
Table 1: Effect of different extracts of edible parts of ginger, leek and GA and their combinations versus atorvastatin on lipid pattern in P-
407 induced hyperlipidemic rats 






Atorvastatin Ginger leek Gum arabic Dose A Dose B 
TC  90.8±3.5 390.3±24.2 227.5±13.9ab 230.4±18.4ᵃᵇ 245.3±24.1ᵃᵇ 238.2±27.3ᵃᵇ 277.7±6.4ᵃᵇ 179.3±13.6ᵃᵇ 
TG  65.1±5.5 509.4±34.9 189.1±11.6ᵃᵇ 156.5±14.8ᵃᵇ 176.8±19.2ᵃᵇ 169.9±8.8ᵃᵇ 208±8.5 ᵃᵇ 140.1±11.4abc 
HDL-C  42.8±1.9 73.3±3.9 52.2±4.6b 69.5±3.2ac 75.8±3.6ac 85.2±4.7abc 42±4.8 b 45.7±3.6b 
LDL-C  35±3.2 215.1±21.4 137.5±9ᵃᵇ 129.6±15.2ᵃᵇ 134.1±22.6ᵃᵇ 119±28.9ᵃᵇ 194.1±8.9ac 105.6±9.5ᵃᵇ 
VLDL-C  13±1.1 101.8±6.9 37.8±2.3ᵃᵇ 31.3±2.9ᵃᵇ 35.3±3.8ᵃᵇ 33.9±1.8ᵃᵇ 41.6±1.7ᵃᵇ 28±2.3abc 
TC: total cholesterol, TG: triglyceride, HDL-C: high-density lipoprotein-cholesterol, LDL-C: low-density lipoprotein-cholesterol, VLDL-C: Very low-
density lipoprotein-Cholesterol, all parameters were measured in (mg/dl) Results are expressed as mean±SEM N=8 animals in each group, 
aSignificant difference from the negative control group at P<0.05, bSignificant difference from the hyperlipidemic control group at P<0.05, 
cSignificant difference from Atorvastatin standard Control group at P<0.05 
 









MWt** Identified compounds 
 
Ref.  
1 0.74 N. D 203 202 ɑ-Curcumene [29]  
3 6.81 N. D 153 152 Neral [29] 
4 7.84 195 N. D 196 Zingerol [30] 
5 8.38 377 N. D 378 12-Gingerol [31] 
6 8.51 N. D 197 196 3-(3',4'-Dihydroxy-5'-methoxyphenyl)-1-propanal [30] 
7 10.52 389 N. D 390 5-hydroxy-1-(3,4-dihydroxy-5-methoxyphenyl)-7-(4-hydroxy-3-
methoxyphenyl)-3-heptanone 
[32] 
8 10.81 389 N. D 390 3-acetoxy-5-hydroxy-1,7-bis(3,4-dihydroxyphenyl)heptane [32] 
9 11.49 405 N. D 406 3,5-dihydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)-7-(4-hydroxy-3-
methoxyphenyl)heptane 
[32] 
10 11.74 285 287 286 Kaempferol [33-35] 
11 11.97 N. D 137 136 β-Phellandrene [29] 
12 12.85 357 N. D 358 Matairesinol [36] 
14 13.71 431 N. D 432 3,5-diacetoxy-1,7-bis(3,4-dihydroxyphenyl)heptane [32] 
15 13.89 505 N. D 506 3,5-diacetoxy-7-(3,4-dihydroxy-5-methoxyphenyl)-1-(4-hydroxy-3,5-
dimethoxyphenyl)heptane 
[32] 
16 14.09 355 379 356 1,7-bis-(4'-Hydroxy-3'-methoxyphenyl)-4-heptene-3-one [37] 
17 14.76 401 N. D 402 2E-Geranial acetal of 
4-Gingerdiol 
[30] 
18  445 N. D 446 3,5-diacetoxy-7-(3,4-dihydroxyphenyl)-1-(4-hydroxy- 
3-methoxyphenyl)heptane 
[32] 
19 15.28 293 317 294 6-Gingerol [30] 
20 15.79 359.3 N. D 360 12-Shogaol [31] 
21 15.92 459 N. D 460 meso and (3S,5S)-3,5-Diacetoxy-1,7-bis-(4'-hydroxy-3'-
methoxyphenyl)heptane 
[30] 
25 16.78 N. D 219 218 (±)-(E)-Nuciferol [29] 
26 16.88 375 N. D 376 12-Gingerdione [30] 
28 17.68 275 277 276 6-Shogaol [37, 38] 
33 18.69 387 N. D 388 1,7-bis-(4'-Hydroxy-3'-methoxyphenyl)-5-methoxyheptan-3-one [30] 
34 18.95 N. D 403 402 12-gingediol [38] 
35 19.43 289 291 290 Methyl 6-shogaol [37] 
36 19.76 N. D 319 318 Methyl (E)-8-shogaol [30] 
37 19.88 N. D 335 334 10-Paradol [30] 
38 20.25 265 N. D 266 4-gingerol [38] 
39 20.34 349 N. D 350 10-gingerol [38] 
40 20.60 N. D 327 326 Methyl Icosanoate [36] 
41 20.72 N. D 373 372 1,7-bis-(4'-Hydroxy-3'-methoxyphenyl)-3,5-heptadione [30] 
42 21.09 295 N. D 296 6-gingerdiol [37, 38] 
43 21.26 415 N. D 416 1-(4'-Hydroxy-3'-methoxyphenyl)-2-nonadecen-1-one [30] 
44 21.26 N. D 205 204 ɑ-Zingiberene [29] 
46 21.62 N. D 205 204 β-sesquiphellandrene [29] 
49 22.11 N. D 387 386 1-(4'-Hydroxy-3',5'-dimethoxyphenyl)-7-(4'-hydroxy-3'-methoxyphenyl)-
4-hepten-3-one 
[30] 
51 22.51 N. D 333 332 10-Shogaol [30] 
52 22.69 293 N. D 294 1-Hydroxy-6-paradol [30] 
60 24.16 277 279 278 6-Paradol [37] 
61 24.28 N. D 377 376 3,5-dihydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)heptane [32] 
63 24.61 N. D 205 204 α-Farnesene [29] 
64 25.01 N. D 353 352 10-Gingerdiol [37] 
65 25.19 279 N. D 280 6-Dihydroparadol [37] 
66 25.28 N. D 353 352 5-Acetoxy-7-gingerdiol [37] 
67 25.58 N. D 309 308 Methyl 6-gingerol [30] 
71 26.26 N. D 409 408 Diacetoxy-8-gingerdiol [30] 
73 26.50 N. D 409 408 10-Gingerdiol, cyclic methyl ortho ester [30] 
 
76 26.88 N. D 307 
79 27.35 N. D 381 
80 28.06 N. D 309 
81 28.34 N. D 437 
82 28.48 N. D 297 
84 28.79 N. D 311 
85 29.10 N. D 371 
93 30.89 N. D 223 
95 31.12 N. D 223 
**MWt. = molecular weight, *RT= retention time
 
LC-ESI-MS/MS analysis 
An overall of 56 compounds was tentatively identified in the ethanol 
extracts of ginger (root and rhizome) (table 2). Four of the major 
constituents were subjected to further MS2 fragmentation (table 3)
 
Fig. 1: Percentage change of TC, TG, HDL-C, LDL
hyperlipidemic rats, Dose A =ethanol extract of ginger 200 mg
g/kg bw, Dose B= ethanol extract of ginger 400 mg/kg
Table 3: MS2 fragmentation 
Cpd No Peak No. Name (
MS(
1 19 6-Gingerol 293
2 28 6-Shogaol 275
3 51 10-Shogaol N
4 65 6-Dihydroparadol 279
MWt. = molecular weight, ND= not detected, cpd= compound
 









1 0.75 N. D 175 
2 0.83 149 N. D 
3 1.03 150 N. D 
4 1.35 130 132 
5 2.09 164 166 
7 4.12 181 N. D 
8 7.20 431 N. D 
9 8.46 N. D 197 
10 8.64 112.9 N. D 
11 9.48 463 N. D 
12 9.62 178 N. D 
13 10.32 N. D 284 
14 10.48 447 449 
16 11.74 285 287 
17 12.13 N. D 181 
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showing the characteristic fragmentation pattern of gingerol related 
compounds with a base peak at 
benzylic cleavage product associated with the 4'
methoxy benzyl cation in all four compounds. 6
major constituent at m/z 295 [M+H]
-C and VLDL-C for all tested samples against atorvastatin control group in P
/kg bw, leek 250 mg/kg bw and 30% aqueous solution of gum arabic 3.75 
 bw, leek 500 mg/kg bw and 30% aqueous solution of gum Arabic 7.5 g/kg
Results are expressed as mean±SEM n=8 
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Allium ampeloprasum var. porrum (L.)
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182 Dipropyl trisulfide 
432 Apigenin-7-glucoside 
196 Hydroferulic acid 
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19 13.24 285 287 286 kaempferol [42; 45] 
21 18.24 N. D 273 272 Naringenin [42; 44] 
22 18.69 N. D 343 342 sucrose [39] 
24 20.11 N. D 317 316 Isorhamnetin, Rhamnetin [17]  
26 20.39 N. D 257 256 palmitic acid [40] 
27 20.72 N. D 355 354 Chlorogenic acid [44] 
28 21.26 295 297 296 Phytol [40] 
29 21.46 577 N. D 578 Apigenin-7-O-neohespiroside [39] 
32 22.44 N. D 537 536 kampherol dervatives [39] 
33 22.61 579 N. D 580 Naringin [47] 
38 23.81 459 N. D 460 (25R)-5α-spirostane-3β,6β-diol-2,12-dione (Porrigenin C) [46, 47] 
40 24.02 N. D 225 224 Sinapenic acid [42, 44] 
41 24.16 277 279 278 ɑ-linolenic acid [48] 
42 24.40 N. D 499 498 Kaempferol hexose [39] 
46 25.17 279 N. D 280 linoleic acid [48] 
47 25.44 N. D 303 302 Quercetin [42; 44] 
48 25.54 N. D 303 302 Hesperetin [42] 
52 26.52 N. D 314 313 N-feruloyltyramine [46] 
57 28.29 N. D 271 270 Apigenin [44] 
59 28.58 N. D 285 284 Acacetin [46] 
61 29.02 N. D 536 535 Kaempferol deoxyhexose [39] 
63 29.47 N. D 611 610 Rutin [44] 
64 29.85 N. D 684 683 Kaempferol deoxyhexose [39] 
69 30.60 N. D 505 504 kestose [39] 
70 30.68 N. D 535 534 Kaempferol malonyl hexose [39] 
71 30.79 N. D 603 602 Kaempferol derivative [39] 
73 31.15 197 199 198 Syringic acid [44] 
**MWt. = molecular weight. *RT= retention time  
 













1 5 Ethiin 164 166 165 28,42,77,79,103,118,120 ID: HMDB0029432  
2 11 Quercetin 
glucoside 
463 N. D 464 151,243,255, 271, 299,300,301 ID: PR100677  
3 14 astragaline 447 449 448 107,121,153,165,287 PR100243 
4 19 kaempferol 285 287 286 107,121,133,153,165, 
181,269,287 
ID: PB004123 
 MWt. = molecular weight, ND= not detected, Results of HPLC quantitative analysis of sugars after hydrolysis of the aqueous solution of gum arabic 
tabulated in (table 6). The major constituents were found to be galactose, arabinose and glucouronic acid. 
 
Table 6: Sugars and uronic acids analysed by HPLC in GA after hydrolysis 
Peak no. Saccharides RT *(min) (%) Saccharides after hydrolysis  
1 Glucuronic acid 5.141 6.60 
2 Stachyose 5.442 0.20 
3 Galacturonic 5.624 0.06 
4 Sucrose 6.372 0.04 
5 Glucose 7.425 0.63 
6 Galactose 8.719 19.36 
7 Arabinose 10.430 15.76 
8 Manitol 14.267 0.006 
9 Sorbitol 18.726 0.004 
 *RT= retention time 
 
As for the leek ethanol extract, 45 compounds were tentatively 
identified (table 4) and four of its major constituents were further 
fragmented by MS2. It is the first record for MS2 analysis of ethiin 
detected as the major component in leek extract (table 5). It showed 
the protonated molecular ion at m/z 166 [M+H]+. The characteristic 
ion fragment at m/z 103 was detected due to loss of both -COOH and 
-NH2 groups and rearranging of the parent protonated molecule. 
CONCLUSION  
It can be concluded that the co-administration of a group of natural 
extracts with each other in certain concentrations proved to be more 
effective than the use of synthetic drugs or the use of a single 
component. This may be due to the multi-mechanism of action of the 
extracts and/or they may be having less adverse effects. Such a 
combination can be used as prophylactic management or as a 
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